Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.832
AS - Asia 6.029
EU - Europa 4.676
SA - Sud America 940
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 173
OC - Oceania 89
Totale 23.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.419
SG - Singapore 1.829
CN - Cina 1.505
IT - Italia 1.413
GB - Regno Unito 975
BR - Brasile 662
HK - Hong Kong 656
VN - Vietnam 607
SE - Svezia 467
DE - Germania 325
FI - Finlandia 309
BD - Bangladesh 270
FR - Francia 257
RU - Federazione Russa 223
KR - Corea 200
CA - Canada 197
JP - Giappone 163
TR - Turchia 160
IN - India 154
ID - Indonesia 147
UA - Ucraina 121
IE - Irlanda 111
AR - Argentina 97
MX - Messico 97
NL - Olanda 83
AU - Australia 79
BG - Bulgaria 72
PK - Pakistan 56
IQ - Iraq 53
TN - Tunisia 51
PL - Polonia 50
LT - Lituania 46
ZA - Sudafrica 41
EC - Ecuador 37
MY - Malesia 36
CL - Cile 34
CO - Colombia 34
ES - Italia 34
AT - Austria 27
PE - Perù 25
PT - Portogallo 25
VE - Venezuela 24
PH - Filippine 23
AE - Emirati Arabi Uniti 21
HU - Ungheria 20
SA - Arabia Saudita 20
JO - Giordania 17
CR - Costa Rica 16
NP - Nepal 16
DK - Danimarca 15
EG - Egitto 15
BE - Belgio 14
BZ - Belize 14
HN - Honduras 14
KE - Kenya 14
MA - Marocco 14
RS - Serbia 14
NI - Nicaragua 13
DZ - Algeria 12
IR - Iran 12
JM - Giamaica 11
RO - Romania 11
CH - Svizzera 10
GT - Guatemala 10
NZ - Nuova Zelanda 10
TT - Trinidad e Tobago 10
PY - Paraguay 9
TH - Thailandia 9
TW - Taiwan 9
UZ - Uzbekistan 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
EE - Estonia 7
IL - Israele 7
LB - Libano 7
LV - Lettonia 7
OM - Oman 7
PR - Porto Rico 7
CZ - Repubblica Ceca 6
SC - Seychelles 6
SV - El Salvador 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
CY - Cipro 5
GR - Grecia 5
HR - Croazia 5
EU - Europa 4
GY - Guiana 4
LU - Lussemburgo 4
MD - Moldavia 4
MU - Mauritius 4
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
SY - Repubblica araba siriana 3
Totale 23.704
Salva come PNG Salva come JPEG
Città #
Ashburn 1.338
Santa Clara 1.327
Singapore 1.160
Fairfield 853
San Jose 743
Hong Kong 633
Chandler 507
Council Bluffs 503
Hefei 464
Southend 451
Woodbridge 343
Houston 294
Seattle 283
Wilmington 265
London 264
Nyköping 264
Helsinki 261
Cambridge 242
Beijing 233
Los Angeles 224
Ann Arbor 215
The Dalles 215
New York 194
Ho Chi Minh City 182
Seoul 170
Jacksonville 145
Milan 143
Hanoi 136
Dallas 134
Modena 124
Chicago 122
Dearborn 110
Jakarta 105
San Diego 98
Shanghai 89
Rome 84
Buffalo 81
Moscow 79
Dublin 78
Lauterbourg 71
Sofia 70
Princeton 68
São Paulo 68
Redwood City 64
Tokyo 63
Orem 60
Munich 58
Columbus 56
Bologna 53
Salt Lake City 49
Perth 47
Frankfurt am Main 43
Montreal 42
Izmir 41
Boardman 40
Bremen 39
Eugene 36
Mexico City 36
Atlanta 35
Da Nang 35
Toronto 35
Brooklyn 34
Manchester 33
San Francisco 33
Boston 30
Elk Grove Village 30
Nuremberg 29
Phoenix 29
North Bergen 28
Warsaw 28
Kent 27
Mumbai 27
Chennai 26
Istanbul 26
Bari 25
Falls Church 25
Haiphong 25
Denver 23
Naples 23
Ankara 22
Baghdad 21
Redondo Beach 21
Rio de Janeiro 21
Santiago 21
Amsterdam 20
Las Vegas 19
Paris 19
Turku 19
Dong Ket 18
Johannesburg 18
Philadelphia 18
Guangzhou 17
Ottawa 17
Washington 17
Brasília 16
Catania 16
Quito 16
Stockholm 16
Turin 16
Bogotá 15
Totale 15.149
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.423
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 441
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 429
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 375
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 367
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 365
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 363
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 355
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 351
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 346
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 338
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 337
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 333
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 331
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 331
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 322
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 316
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 314
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 314
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 312
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 298
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 276
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 272
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 272
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 271
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 270
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 269
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 269
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 264
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 257
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 255
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 252
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 250
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 242
Nailfold videocapillaroscopy in antisynthetase syndrome 241
Severe alopecia complicating systemic sclerosis 239
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 237
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 237
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 237
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 235
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 229
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 225
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 223
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 220
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 219
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 218
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 216
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 215
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 212
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 209
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 207
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 203
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 200
Rheumatoid arthritis related interstitial lung disease 199
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 199
Fibrosing interstitial lung disease in primary Sjogren syndrome 196
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 196
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 191
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 191
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 190
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 190
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 189
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 189
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 186
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 185
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 185
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 180
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 178
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 172
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 170
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 168
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 168
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 168
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 166
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 165
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 164
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 162
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 159
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 159
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 155
Granuloma annulare as a possible new adverse effect of topiramate 152
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 152
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 146
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 146
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 145
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 145
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study 144
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 142
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 140
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 138
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 134
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 134
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 131
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 120
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 120
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 118
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 114
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 110
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 110
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 104
Totale 23.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.386 0 0 0 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20254.678 143 69 108 319 961 737 396 205 489 174 451 626
2025/20268.095 533 368 640 920 975 599 1.041 390 882 682 584 481
2026/20272.177 231 549 523 874 0 0 0 0 0 0 0 0
Totale 23.985